Head & Neck A-2 Protocol A Phase I/II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) in Stage III and IV Inoperable Head and Neck Squamous Cell Carcinomas

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - May 1999
Event35th Annual Meeting of the American Society of Clinical Oncology (ASCO) - Atlanta, GA
Duration: May 1 1999 → …

Conference

Conference35th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Period5/1/99 → …

Disciplines

  • Medicine and Health Sciences

Cite this